Akari Therapeutics Plc Annual Share-based Payment Arrangement, Expense in USD from 2010 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Akari Therapeutics Plc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2010 to 2024.
  • Akari Therapeutics Plc Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $1.7M, a 281% increase year-over-year.
  • Akari Therapeutics Plc Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $2.25M, a 95.2% increase year-over-year.
  • Akari Therapeutics Plc annual Share-based Payment Arrangement, Expense for 2024 was $2.25M, a 95.2% increase from 2023.
  • Akari Therapeutics Plc annual Share-based Payment Arrangement, Expense for 2023 was $1.15M, a 105% increase from 2022.
  • Akari Therapeutics Plc annual Share-based Payment Arrangement, Expense for 2022 was $560K, a 78% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $2.25M +$1.1M +95.2% Jan 1, 2024 Dec 31, 2024 10-K 2025-04-15
2023 $1.15M +$590K +105% Jan 1, 2023 Dec 31, 2023 10-K 2025-04-15
2022 $560K +$245K +78% Jan 1, 2022 Dec 31, 2022 8-K 2024-09-06
2021 $315K -$10.9K -3.34% Jan 1, 2021 Dec 31, 2021 20-F 2023-05-01
2020 $326K Jan 1, 2020 Dec 31, 2020 20-F 2023-05-01
2014 $410K +$336K +454% Jan 1, 2014 Dec 31, 2014 10-K 2015-02-11
2013 $74K -$311K -80.8% Jan 1, 2013 Dec 31, 2013 10-K 2015-02-11
2012 $385K +$365K +1825% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-11
2011 $20K +$115K Jan 1, 2011 Dec 31, 2011 20-F 2014-03-24
2010 -$95K Jan 1, 2010 Dec 31, 2010 20-F/A 2013-04-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.